← Back to Search

Dry Needling for Lower Back Pain

N/A
Recruiting
Led By Joel Bialosky, PhD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ages 18 - 65
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately following the assigned intervention
Awards & highlights

Study Summary

This trial will compare the effects of trigger point dry needling to the lower back in a healthy population to see if it has an impact on pain sensitivity.

Who is the study for?
This trial is for healthy adults aged 18-65 without back pain. It's not suitable for non-English speakers, pregnant women, those with sensation-affecting medical conditions, low back surgery history, clotting disorders or on blood thinners, needle/metal allergies, or contraindications to cold applications.Check my eligibility
What is being tested?
The study tests if trigger point dry needling can change pain sensitivity in the lower back of a healthy population. Participants will be randomly placed into two groups: one receiving real dry needling and the other sham (fake) needling that doesn't pierce the skin.See study design
What are the potential side effects?
Potential side effects may include temporary discomfort at the needle site, minor bleeding or bruising. Since sham needles don't penetrate the skin, they carry fewer risks but might cause mild irritation due to placebo effect.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and immediately following the intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and immediately following the intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Cold Thermal Pain Threshold degrees Celsius baseline and Cold Thermal Pain Threshold degrees Celsius immediately following intervention
Change in Heat Thermal Pain Threshold degrees Celsius baseline and Heat Thermal Pain Threshold degrees Celsius immediately following intervention
Change in Pressure Pain Threshold Kilopascals baseline and Pressure Pain Threshold Kilopascals immediately after following intervention
+3 more
Secondary outcome measures
Blinding
Degree to which expectations met
Expectations

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Actual dry needling groupExperimental Treatment1 Intervention
Will receive actual dry needling of the lumbar multifidus with a 50-60mm filiform needle
Group II: Sham dry needling groupPlacebo Group1 Intervention
Will receive needling from a sham needle that is blunted so it does not pierce the skin but has been shown to be valid for being indistinguishable from receiving an actual needle.

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor
1,350 Previous Clinical Trials
719,920 Total Patients Enrolled
Joel Bialosky, PhDPrincipal InvestigatorUniversity of Florida
2 Previous Clinical Trials
86 Total Patients Enrolled

Media Library

Trigger point dry needling Clinical Trial Eligibility Overview. Trial Name: NCT05845697 — N/A
Lower Back Pain Research Study Groups: Actual dry needling group, Sham dry needling group
Lower Back Pain Clinical Trial 2023: Trigger point dry needling Highlights & Side Effects. Trial Name: NCT05845697 — N/A
Trigger point dry needling 2023 Treatment Timeline for Medical Study. Trial Name: NCT05845697 — N/A
~20 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top